Background: Although differences between black and white persons in hemoglobin A 1c (HbA 1c ) values are well established, recent studies suggest that this might not reflect differences in glycemia.
I
n a major change to clinical guidelines, glycated hemoglobin A 1c (HbA 1c ) was recently recommended for use as a diagnostic test for diabetes in the United States (1) . However, there is ongoing debate about the interpretation of HbA 1c values among black persons and the possible need for race-based HbA 1c cut points (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) . Black persons are known to have higher HbA 1c values than their white counterparts in both the presence and absence of diabetes (2, 4, (17) (18) (19) (20) (21) (22) (23) and even in the setting of a low fasting glucose value (13, 19) . It is unclear whether this disparity stems from racial differences in pre-or postprandial glycemia (6, 13, 22) , the tendency of hemoglobin to undergo glycation (5), erythrocyte turnover, or erythrocyte permeability to glucose. Serum glycemic markers, such as fructosamine, glycated albumin, and 1,5-anhydroglucitol, offer ways to evaluate racial disparities in glycemia that are biologically independent of erythrocyte turnover and hemoglobin glycation.
Hemoglobin A 1c results from the glycation of hemoglobin in erythrocytes and represents long-term (2-to 3-month) glycemia. In contrast, fructosamine and glycated albumin reflect the modification of serum proteins (mainly albumin) by glucose and are markers of 2-to 4-week endogenous glucose exposure. 1,5-Anhydroglucitol is a marker of glycemia-induced glycosuria because reabsorption of filtered 1,5-anhydroglucitol in the proximal tubule is competitively inhibited by glucose (24, 25) . Lower serum 1,5-anhydroglucitol levels reflect high circulating glucose levels and the occurrence of glycosuria over the previous 1 to 2 weeks (25-30).
We compared nontraditional serum glycemic markers (glycated albumin, fructosamine, and 1,5-anhydroglucitol) with standard markers (HbA 1c and fasting glucose) in participants in the ARIC (Atherosclerosis Risk in Communities) study to determine whether the documented higher values of HbA 1c in black persons were also observed for serum measures of glycemia. We hypothesized that HbA 1c , fructosamine, and glycated albumin values would be higher in black persons and that 1,5-anhydroglucitol would be lower in black persons, compared with white persons before and after adjustment for fasting glucose concentration.
METHODS

Study Population
We conducted a cross-sectional study of participants from the ARIC study who participated in the ARIC CARMRI (Carotid Magnetic Resonance Imaging) substudy. The ARIC study is an ongoing, community-based prospective cohort trial of 15 792 black and white adults originally enrolled from 1987 to 1989 from 4 U.S. communities (Forsyth County, North Carolina; Jackson, Mississippi; Minneapolis, Minnesota; and Washington County, Maryland) (31-33). Just more than 2000 participants from the original cohort were recruited into the CARMRI substudy from 2004 to 2005 by using a stratified sampling plan (34) . Black participants were enrolled only at the Forsyth County and Jackson field centers. In addition to the magnetic resonance imaging examination, trained technicians did a comprehensive clinical examination, obtained blood specimens, and conducted an interview to obtain information on health status and risk factors. Our final sample was limited to 1719 participants (343 with a history of diabetes and 1376 without) after those who fasted less than 8 hours (n ϭ 20) or who were missing variables of interest (n ϭ 327) were excluded. Of the 424 black participants included in this study sample, most (n ϭ 396) were recruited from the Jackson field center.
Institutional review boards at each clinical site approved the study protocol, and written informed consent was obtained from all participants.
Measurement of Glycemic Markers
Hemoglobin A 1c was measured from whole blood samples as part of the original CARMRI protocol by using the Tina-quant II method (Roche Diagnostics, Basel, Switzerland) implemented on a Roche Hitachi 911 Analyzer. This method is standardized to the Diabetes Control and Complications Trial assay. In 2009, we measured glycated albumin (Asahi Kasei Lucica GA-L, Tokyo, Japan), fructosamine (Roche Diagnostics), and 1,5-anhydroglucitol (GlycoMark, Winston-Salem, North Carolina) from stored serum specimens by using a Roche Modular P800 system. The interassay coefficients of variation were 2.7% for glycated albumin, 3.7% for fructosamine, and 4.8% for 1,5-anhydroglucitol.
Other Variables of Interest
Other measurement protocols in ARIC CARMRI were identical to those implemented in the original ARIC study (34) . Blood samples were assayed for total and high-density lipoprotein cholesterol, glucose, and highsensitivity C-reactive protein by using conventional techniques. Body mass index was computed from measured height and weight. Information on cigarette smoking and alcohol consumption was elicited during the interview. Resting systolic blood pressure (average of 2 readings) was measured by using a random-zero sphygmomanometer. Participants were asked to bring current medications to the visit, and information on cholesterol-and blood pressurelowering medications was also obtained during the interview. Diabetes history was determined by use of glucoselowering medications or a self-reported physician diagnosis of diabetes. History of coronary heart disease included a reported history of coronary heart disease of an adjudicated coronary heart disease event during follow-up to the CARMRI visit (33) .
Statistical Analysis
Characteristics of the study population were calculated both overall and by black or white race. We compared mean values of each glycemic marker by race separately in persons with and without a history of diagnosed diabetes. We used multivariable linear regression models to assess the independent association of race with each glycemic marker in original units and expressed in SD units (standardized regression) after adjustment for confounding factors and fasting glucose concentration. All analyses were weighted by the inverse of the sample fractions in the study sampling strata by using methods for the analysis of complex sample survey design data (34) . All statistical analyses were performed by using Stata/SE, version 11.0 (StataCorp, College Station, Texas).
Role of the Funding Source
The National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases funded the study. The funding source had no role in the study design, conduct, interpretation of results, or in the decision to submit the manuscript for publication. Table 1 shows the characteristics of the study population. Black participants were less likely to be men and had a higher body mass index, higher total cholesterol concentration, and higher C-reactive protein concentration than white persons. Compared with white persons, black
RESULTS
Context
At similar fasting glucose levels, black persons have higher hemoglobin A 1c (HbA 1c ) levels than white persons. Whether these differences reflect differences in preprandial and postprandial glucose levels or in erythrocyte turnover and hemoglobin glycation is unknown. If the former is the case, then HbA 1c targets should not consider patients' ethnicity; if the latter is true, then targets should take ethnicity into account.
Contribution
Among 343 people with and 1376 without diabetes, black persons had higher HbA 1c levels. Other markers (glycated albumin, fructosamine, and 1,5-anhydroglucitol levels) also reflected greater glycemia in black persons than in white persons.
Implication
Differences in erythrocyte turnover or hemoglobin glycation do not seem to explain racial differences in HbA 1c levels.
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Original Research Racial Differences in Glycemic Markers persons were more likely to have diabetes, to have less than a high school education, or to be receiving blood pressure-lowering medication. In contrast, black persons were less likely to be current drinkers, have a history of coronary heart disease, and be taking cholesterollowering medications.
Differences in each glycemic marker by race and diabetes status are shown in Table 2 . In this unadjusted comparison, black persons had significantly higher HbA 1c , glycated albumin, and fructosamine values than white persons with and without diabetes. The 1,5-anhydroglucitol level, which is inversely related to glycosuria, was lower in black 
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Racial Differences in Glycemic Markers persons than in white persons, although this difference was only of borderline statistical significance. The Figure shows the adjusted standardized differences (SD units) in glycemic markers. Even after adjustment for all covariates and fasting glucose concentration, black persons had higher HbA 1c , glycated albumin, and fructosamine levels than white persons. The standardized difference between black and white persons for serum fructosamine and serum glycated albumin was larger than that for fasting glucose and similar to the difference observed for HbA 1c (that is, about 0.5 SDs higher in black persons than in white persons). After adjustment, racial differences in fasting glucose and 1,5-anhydroglucitol were statistically significant only among persons without a history of diabetes. Tables 3 and 4 show the crude and adjusted mean differences by race for each glycemic marker (black minus white) in original and SD units. In sensitivity analyses, we compared weighted and unweighted results to evaluate the effect of the complex sample survey design. Results were similar in unweighted analyses that did not account for the complex sampling design (data not shown). Because geographic differences cannot be easily separated from race differences because most black participants were recruited from the Jackson field center, we repeated our analyses by using data only from the Forsyth County field center (which recruited both black persons and white persons).
Results from this subanalysis (data not shown) were very similar.
DISCUSSION
Our results confirm that HbA 1c values are higher in black persons than white persons, even in analyses stratified by diabetes status and after adjustment for known confounding factors and for fasting glucose concentration. We also demonstrated that markers of serum protein Adjusted for age, sex, systolic blood pressure, hypertension medication use, body mass index, low-density and high-density lipoprotein cholesterol levels, cholesterol-lowering medication use, cigarette smoking, prevalent coronary heart disease, education level, log-transformed C-reactive protein level, family history of diabetes, and fasting glucose level (except for the model of fasting glucose). * Serum 1,5-anhydroglucitol is inversely related to glycemia-induced glycosuria. * To convert to mmol/L, multiply by 0.0555. † P Ͻ 0.001. ‡ P Ͻ 0.01. § Model 1 is adjusted for age, sex, systolic blood pressure, hypertension medications use, body mass index, low-density and high-density lipoprotein cholesterol levels, cholesterollowering medication use, cigarette smoking, prevalent coronary heart disease, education level, log-transformed C-reactive protein level, and family history of diabetes. Also adjusted for serum albumin level. ¶ P Ͻ 0.05. ** Model 2 includes variables in model 1 and fasting glucose level.
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glycation-glycated albumin and fructosamine-are higher in black persons than in white persons, with differences similar in magnitude to those observed for HbA 1c . Similarly, 1,5-anhydroglucitol levels, which are lowered by postprandial glycemic excursions, were lower in black persons than in white persons, but these results were weaker. Our results are consistent with other analyses from the ARIC study that demonstrate equal performance of HbA 1c in black and white persons for the prediction of vascular events, mortality, and microvascular disease (35, 36) . As in previous studies (2, 13), fasting glucose concentrations were similar in black persons and white persons. Of note, the study with the most accurate representation of true glycemic exposure over time, the A1c-Derived Average Glucose study, demonstrated that a single fasting glucose value is a poor measure of average glycemia, whereas average blood glucose-assessed by using continuous blood glucose monitoring-correlates very highly with HbA 1c (r ϭ 0.89) (37). This implies that racial differences in HbA 1c might be driven by racial differences in nonfasting glycemia.
Our study had several limitations. First, relatively few persons had a history of diagnosed diabetes (n ϭ 343). Second, we had measurements of each glycemic marker at only 1 point in time in the CARMRI Study, a subsample of the ARIC population. Third, the cross-sectional design precluded us from examining the long-term clinical implications of the observed racial differences in glycemic makers. Furthermore, because all black participants were recruited at 2 study sites in the ARIC CARMRI study (Jackson, Mississippi, and Forsyth County, North Carolina) we could not definitively separate the effects of race from those of region, although the racial differences in HbA 1c and fasting glucose observed here are of similar magnitude and direction to those observed in the National Health and Nutrition Examination Survey and other cohorts. Finally, we had direct measurements of glucose only on fasting samples; we lacked direct data on glycemia at other time points.
Strengths of this study were the rigorous measurement of diabetes risk factors, the biracial community-based sample, the comparative analyses of different glycemic markers, and excellent laboratory performance demonstrated for each of the serum glycemic markers.
Glycated albumin, fructosamine, and 1,5-anhydroglucitol are unaffected by hematologic factors. Thus, the main implication of our study is that racial disparities in HbA 1c values are not explained by racial differences in hemoglobin glycatability, erythrocyte turnover, or erythrocyte permeability. One interpretation of our findings is that higher HbA 1c reflects higher concentrations of nonfasting glycemia in black persons compared with their white counterparts. Previous studies have documented that black persons consume diets of higher glycemic index and glycemic load than white persons (38, 39)-such diets could produce higher concentrations of postprandial glycemia. However, without direct measurements of nonfasting glycemia, we were unable to confirm this interpretation. Future research should directly compare nonfasting glycemia in black persons and white persons and investigate dietary and nondietary factors as possible mediators. 
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